An assessment of the utility of the yeast GreenScreen assay in pharmaceutical screening

Mutagenesis

Volumn 20, Issue 6, 2005, Pages 449-454

  Van Gompel, J ^b   Woestenborghs, F ^b   Beerens, D ^b   Mackie, C ^b   Cahill, P A ^a   Knight, A W ^a   Billinton, N ^a   Tweats, D J ^c   Walmsley, R M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^c SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIVASTINE; ALENDRONIC ACID; AMIFOSTINE; AMPHOTERICIN B; AMPRENAVIR; ANAGRELIDE; AZELASTINE; BETAXOLOL; CETIRIZINE; CICLOPIROX; CITALOPRAM; CLOMIFENE; DICLOFENAC; DIFLUNISAL; DIHYDROERGOTAMINE; DNA; DONEPEZIL; DOXYCYCLINE; ETODOLAC; FELODIPINE; FENOFIBRATE; GREEN FLUORESCENT PROTEIN; GRISEOFULVIN; ITRACONAZOLE; LAMOTRIGINE; LANSOPRAZOLE; METFORMIN; METHYLPHENIDATE; RAD54 PROTEIN; UNINDEXED DRUG;

ARTICLE; ASSAY; CONTROLLED STUDY; DNA DAMAGE; MARKETING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; REPRODUCIBILITY; SCREENING; YEAST CELL; YEAST GREENSCREEN ASSAY;

BIOLOGICAL ASSAY; CARCINOGENICITY TESTS; CARCINOGENS; CELL COUNT; DNA DAMAGE; DRUG EVALUATION, PRECLINICAL; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; MUTAGENICITY TESTS; REPRODUCIBILITY OF RESULTS; SACCHAROMYCES CEREVISIAE;

EID: 29144534997     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/gei062     Document Type: Article

References (15)

1. Reifferscheid,G., Heil,J., Oda,Y. and Zahn,R.K. (1991) A microplate version of the SOS/umu-test for rapid detection of genotoxins and genotoxic potentials of environmental samples. Mutat. Res., 253, 215-222.
2. Yasunaga,K., Kiyonari,A., Oikawa,T., Naoki Abe,N. and Yoshikawa,K. (2004) Evaluation of the Salmonella umu test With 83 NTP Chemicals. Environ. Mol. Mutagen., 44, 329-345.
3. van der Lelie,D., Regniers,L., Borremans,B., Provoost,A. and Verschaeve,L. (1997) The VITOTOX® test, an SOS bioluminescence Salmonella typhimurium test to measure genotoxicity kinetics. Mutat. Res., 389, 279-290.
4. Fluckiger-Isler,S., Baumeister,M., Braun,K., Gervais,V., Hasler-Nguyen,N., Reimann,R., Van Gompel,J., Wunderlich,H.-G. and Engelhardt,G. (2004) Assessment of the performance of the Ames II™ assay: a collaborative study with 19 coded compounds. Mutat. Res., 558, 181-197.
5. Walmsley,R.M., Billinton,N. and Heyer,W.-D. (1997) Green fluorescent protein as a reporter for the DNA damage-induced gene RAD54 from Saccharomyces cerevisiae. Yeast, 13, 1535-1545.
6. Billinton,N., Barker,M.G., Michel,C.E., Knight,A.W., Heyer,W.-D., Goddard,N.J., Fielden,P.R. and Walmsley,R.M. (1998) Development of a green fluorescent protein reporter for a yeast genotoxicity biosensor. Biosensors and Bioelectronics, 13, 831-838.
7. Knight,A.W., Goddard,N.J., Fielden,P.R., Gregson,A.L., Billinton,N., Barker,M.G. and Walmsley,R.M. (2000) The application of fluorescence polarization for the enhanced detection of green fluorescent protein (GFP) in the presence of cellular auto-fluorescence and other green fluorescent compounds. The Analyst, 125, 499-506.
8. Afanassiev,V., Sefton,M., Anantachaiyong,T., Barker,M.G., Walmsley,R.M. and Wölfl,S. (2000) Application of yeast cells transformed with GFP expression constructs containing the RAD54 or RNR2 promoter as a test for the genotoxic potential of chemical substances. Mutat. Res. Genet. Toxicol. Environ. Mutagenesis, 464, 297-308.
9. Cahill,P.A., Knight,A.W., Billinton,N., Barker,M.G., Walsh,L., Keenan,P.O., Williams,C.V., Tweats,D.J. and Walmsley,R.M. (2004) The GreenScreen® genotoxicity assay: a screening validation programme. Mutagenesis, 19, 105-119.
10. Phillips,D.H., (2004) The pros and cons of publishing genetic toxicology studies in which the identities of the compounds are withheld. Mutagenesis, 19, 1.
11. Cormack,B.P., Bertram,G., Egerton,M., Gow,N.A.R., Falkow,S. and Brown,A.J.P. (1997) Yeast-enhanced green fluorescent protein (yEGFP): a reporter of gene expression in Candida albicans. Microbiology, 143, 303-311.
12. Snyder,R.D. and Green,J.W.(2001) A review of the genotoxicity of marketed pharmaceuticals. Mutat. Res., 488, 151-169.
13. Physicians' Desk Reference 2004, Thomson PDR, Montvale, NJ, USA.
14. Ishidate,M. Jr, Harnois,M.C. and Sofuni,T. (1988) A comparative analysis of data on the clastogenicity of 951 chemical substances tested in mammalian cell cultures. Mutat. Res. 195, 151-213.
15. Cooper,J.A., Saracci,R. and Cole,P. (1979) Describing the validity of carcinogen screening tests. Br. J. Cancer, 39, 87-89.